BioPharm International-04-01-2013

First gene therapy and plant-based expression vector products approved in 2012.

The author outlines the need for custom-cell products.

Manufacturing Best Practices

April 01, 2013

Benchmarking can be a useful tool to improve manufacturing practices.

Perspectives on Outsourcing

April 01, 2013

An innovative approach to capacity management.

Have FDA initiatives improved manufacturing quality?

Latin America's diverse growing market seeks regulatory harmonization.

The authors propose a roadmap for analytical lifecycle development.

Opioid abuse generates calls for efforts to curb distribution.

Guest Editorial

April 01, 2013

Sound policies are needed to govern the substitution of interchangeable biologics.

Burrill on Biotech

April 01, 2013

Early-stage companies are finding alternatives to venture capital.

Applications of ZFN technology in biopharmaceutical cell-line engineering.

Ontario-area scientists discuss approaches to development of stem-cell therapies.

European Beat

April 01, 2013

EU authorities are stepping up their efforts to incorporate QbD principles.

The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.

Global Reports

April 01, 2013

The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.

Click the title above to open the BioPharm International April 2013 issue in an interactive PDF format.